Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations

The unprecedented coronavirus SARS-CoV-2 outbreak at Wuhan, China, caused acute respiratory infection to humans. There is no precise vaccine/therapeutic agents available to combat the COVID-19 disease. Some repurposed drugs are saving the life of diseased, but the complete cure is relatively less. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnan, Jaganathan, Kandasamy, Saravanan, Iruthayaraj, Ancy, Magudeeswaran, Sivanandam, Chinnasamy, Kalaiarasi, Poomani, Kumaradhas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844105/
https://www.ncbi.nlm.nih.gov/pubmed/33512650
http://dx.doi.org/10.1007/s12010-020-03475-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844105/
https://www.ncbi.nlm.nih.gov/pubmed/33512650
http://dx.doi.org/10.1007/s12010-020-03475-8

Ejemplares similares